Gut microbiome alterations in preclinical Alzheimer's disease.
<h4>Background</h4>Although some human studies have reported gut microbiome changes in individuals with Alzheimer's disease (AD) dementia or mild cognitive impairment (MCI), gut microbiome alterations in preclinical AD, i.e., cerebral amyloidosis without cognitive impairment, is lar...
Main Authors: | Joon Hyung Jung, Gihyeon Kim, Min Soo Byun, Jun Ho Lee, Dahyun Yi, Hansoo Park, Dong Young Lee, KBASE Research Group |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2022-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0278276 |
Similar Items
-
Gut microbiome alterations in preclinical Alzheimer’s disease
by: Joon Hyung Jung, et al.
Published: (2022-01-01) -
Associations of thyroid hormone serum levels with in-vivo Alzheimer’s disease pathologies
by: Hyo Jung Choi, et al.
Published: (2017-08-01) -
Body mass index and two-year change of in vivo Alzheimer’s disease pathologies in cognitively normal older adults
by: Seunghoon Lee, et al.
Published: (2023-06-01) -
Synergistic interaction between APOE and family history of Alzheimer’s disease on cerebral amyloid deposition and glucose metabolism
by: Dahyun Yi, et al.
Published: (2018-08-01) -
Sleep experiences during different lifetime periods and in vivo Alzheimer pathologies
by: Young Min Choe, et al.
Published: (2019-09-01)